Literature DB >> 7813113

Interferon-gamma (IFN-gamma) production by human T lymphocytes upon Legionella pneumophila stimulation in vitro.

K Kitsukawa1, A Nakamoto, H Koito, Y Matsuda, A Saito, H Yamamoto.   

Abstract

In vitro immune responses to Legionella pneumophila were investigated. When human peripheral blood lymphocytes (PBL) from healthy volunteers were stimulated with formalin-killed L. pneumophila for 7 days in vitro, strong proliferative responses were observed. The responding cells were shown to be a CD4 T cell subset. It was also found that the CD4 T cells secreted significant amounts of IFN-gamma into the PBL culture supernatant. The production of IFN-gamma and IL-4 by PBL was measured semiquantitatively by reverse transcriptase-assisted polymerase chain reaction (RT-PCR) methods. Formalin-killed or live L. pneumophila-stimulated PBL expressed the mRNA for IFN-gamma but not the mRNA for IL-4. The results suggest that the whole bacterium, as opposed to the supernatant, predominantly stimulates Th1 type helper T cells. The cloned T cells specific for L. pneumophila expressed the mRNA for IFN-gamma but not for IL-4. In contrast to formalin-killed or live L. pneumophila stimulation, when PBL were stimulated with the bacterial culture supernatant, the proliferating T cells produced the mRNA for IL-4 as well as for IFN-gamma. A significant correlation between the proliferative response to formalin-killed L. pneumophila and IFN-gamma release in culture was observed (r = 0.6932, P < 0.001) in PBL from 30 healthy volunteers. From these in vitro studies, it is suggested that the whole L. pneumophila bacterium and their soluble antigens stimulate T cells in a manner which results in a different pattern of cytokine production.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7813113      PMCID: PMC1534145          DOI: 10.1111/j.1365-2249.1995.tb03475.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Legionella pneumonia and AIDS.

Authors:  A A Allam; S L Kamholz
Journal:  Chest       Date:  1989-03       Impact factor: 9.410

2.  The diagnosis of Legionnaires' disease.

Authors:  T F Tsai; D W Fraser
Journal:  Ann Intern Med       Date:  1978-09       Impact factor: 25.391

3.  An immunoprotective molecule, the major secretory protein of Legionella pneumophila, is not a virulence factor in a guinea pig model of Legionnaires' disease.

Authors:  S J Blander; L Szeto; H A Shuman; M A Horwitz
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

4.  Macrophage-activating T-cell factor(s) produced in an early phase of Legionella pneumophila infection in guinea pigs.

Authors:  Y Nikaido; S Yoshida; Y Goto; Y Mizuguchi; A Kuroiwa
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

5.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions.

Authors:  M Yamamura; K Uyemura; R J Deans; K Weinberg; T H Rea; B R Bloom; R L Modlin
Journal:  Science       Date:  1991-10-11       Impact factor: 47.728

6.  Legionnaires' disease: description of an epidemic of pneumonia.

Authors:  D W Fraser; T R Tsai; W Orenstein; W E Parkin; H J Beecham; R G Sharrar; J Harris; G F Mallison; S M Martin; J E McDade; C C Shepard; P S Brachman
Journal:  N Engl J Med       Date:  1977-12-01       Impact factor: 91.245

7.  Induction of interferon-gamma and tumor necrosis factor by Legionella pneumophila: augmentation of human neutrophil bactericidal activity.

Authors:  D K Blanchard; H Friedman; T W Klein; J Y Djeu
Journal:  J Leukoc Biol       Date:  1989-06       Impact factor: 4.962

8.  Natural and acquired resistance to Leishmania: cellular activation by Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of natural killer (NK) cells.

Authors:  H Akuffo; K Maasho; R Howe
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

9.  Vaccination with Legionella pneumophila membranes induces cell-mediated and protective immunity in a guinea pig model of Legionnaires' disease. Protective immunity independent of the major secretory protein of Legionella pneumophila.

Authors:  S J Blander; M A Horwitz
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

10.  Distinct types of lung disease caused by functional subsets of antiviral T cells.

Authors:  W H Alwan; W J Kozlowska; P J Openshaw
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Molecular pathogenesis of infections caused by Legionella pneumophila.

Authors:  Hayley J Newton; Desmond K Y Ang; Ian R van Driel; Elizabeth L Hartland
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

2.  Serum cytokines in patients with Legionella pneumonia: relative predominance of Th1-type cytokines.

Authors:  K Tateda; T Matsumoto; Y Ishii; N Furuya; A Ohno; S Miyazaki; K Yamaguchi
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

3.  Transient transgenic expression of gamma interferon promotes Legionella pneumophila clearance in immunocompetent hosts.

Authors:  J C Deng; K Tateda; X Zeng; T J Standiford
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

Review 4.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.